Latest Breaking News On - John puisis - Page 1 : vimarsana.com

CRISPR Tx finds CMO in Sanofi leader—Chutes & Ladders

CRISPR Tx finds CMO in Sanofi leader—Chutes & Ladders
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Julianne brunoNaimish patelNicole gormleyKronos bioNovartis linkedinJohn puisisDeborah knobelmanJeffrey youngHarpreet singhJohn bishopAeglea biotherapeuticsRachel shaGabrielle massonJenny marloweMichael hanleyRoche genentech

Cour Pharmaceuticals CEO John Puisis talks $105M funding round

Puisis spoke with MM+M about Cour Pharmaceuticals' funding, the autoimmune treatment space and the potential of Chicago’s biotech scene.

United statesNorthwestern universityJohn puisisCour pharmaceuticalsBristol myers squibb

This Biotech Startup Just Raised $105M to Extinguish Inflammation at the Source

Cour Pharmaceuticals’ nanoparticles reprogram the immune system to stop inflammation behind autoimmune disease. Three big pharma companies joined the startup’s Series A financing, which will fund clinical trials in type 1 diabetes and myasthenia gravis.

Sonoma biotherapeuticsJohn puisisStephen millerProvention bioCour pharmaceuticalsRd fundRoche venture fundNorthwestern universityBristol myers squibbIronwood pharmaceuticalsPfizer breakthrough growth initiativeAbata therapeuticsQuell therapeuticsTolera therapeuticsTakeda pharmaceuticalWhile rystiggo

COUR Raises $105M to Advance Tolerogenic Nanoparticles

COUR Raises $105M to Advance Tolerogenic Nanoparticles
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

United statesNorthwestern universityJohn puisisLonnied sheaStevep millerBristol myers squibbPfizer breakthrough growth initiativeRoche venture fundRd fundIronwood pharmaceuticalsNorthwestern university feinberg school of medicineMccormick school of engineeringTakeda pharmaceuticalsCour pharmaceutical development companyFeinberg schoolMccormick school

Cour gets $105M, pharma help to reprogram autoimmune disease

BioPharma

John puisisNorthwestern universityIronwood pharmaceuticalsBristol myers squibbCour pharmaceuticalsDive briefAlpha wave venturesBristol myers